Media Summary: Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; mRNA-1273 Clinical Development; Pfizer/BioNTech COVID-19 ... Introduction; Overview of myocarditis and pericarditis; Update on COVID-19 vaccine safety, including myocarditis after mRNA ... EtR Framework: Public Health Problem, Resource Use and Equity Domains Discussion ; Values, Acceptability and Feasibility ...
November 2020 Acip Meeting Welcome - Detailed Analysis & Overview
Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; mRNA-1273 Clinical Development; Pfizer/BioNTech COVID-19 ... Introduction; Overview of myocarditis and pericarditis; Update on COVID-19 vaccine safety, including myocarditis after mRNA ... EtR Framework: Public Health Problem, Resource Use and Equity Domains Discussion ; Values, Acceptability and Feasibility ... Coronavirus Disease 2019 (COVID-19) Vaccines Introduction; Overview of COVID-19 vaccine safety; Enhanced vaccine safety ... Introductions; BNT-162b2 COVID-19 vaccine BLA safety and efficacy data. Prioritization frameworks; Phase 1 allocation for COVID-19 vaccine: Work Group considerations.
Introductions; Coronavirus Disease 2019 (COVID-19) Vaccines: Introduction; Safety and immunogenicity for a 3rd dose of ... Introduction, Meningococcal Vaccines Session ; Safety and immunogenicity of MenQuadfi MenACWY-TT (MenQuadfi): EtR, ...
